Ketrosden Triasmitra Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Ketrosden Triasmitra Tbk. trades at Rp955 (market cap 2.64T, 92.24M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Ketrosden Triasmitra Tbk. is far larger — about 15.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Ketrosden Triasmitra Tbk. is more actively traded (92.24M versus 324K). Which is the better fit depends on your goals.
| KETR | OBAT | |
|---|---|---|
Market Cap | 2.64T | 166.01B |
Volume | 92.24M | 324K |
Lot | 922.38K | 3.24K |
Turnover | 90.37B | 77.68M |
Average Price | 979.8 | 239.75 |
Value | 90.37B | 77.68M |
Indicative Equilibrium Price | 955 | 240 |
Indicative Equilibrium Volume | 29.3K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Ketrosden Triasmitra Tbk was established base on Notarial Deed No.179 of Pudji Redjeki Irawati S.H., dated November 25, 1994.
Read more on KETR →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →